ADPKD clinical study (Kidney study)
clinical study evaluating an investigational drug for adults with Autosomal Dominant Polycystic Kidney Disease (ADPKD).
Study details:
Join a clinical study evaluating an investigational drug for adults with Autosomal Dominant Polycystic Kidney Disease (ADPKD) caused by a confirmed PKD1 mutation, and help researchers understand a potential new treatment approach that targets the underlying genetic cause of the disease.
Eligibility criteria
Researchers look for people who fit a certain description, called eligibility criteria. See if you qualify.
Inclusion criteria
Eligibility
Age eligible for study : N/A
Healthy volunteers accepted : No
Gender eligible for study: ALL
Things to know
Study dates
Study start: 2026-08-30
Primary completion:
Study completion finish:
Study type
No type found
Phase
- Phase I
Study ID
CLINIC-F1C94F6C61AF4
Intervention or treatment
No interventions found
Conditions
You may be eligible to participate in this trial based on your search. Check eligibility by answering some questions.
Research sites nearby
Closest Location:
Research site
Select from list below to view details:
Research site
Not found, Not found
Linear Clinical Research
Nedlands (Perth), Western Australia (WA), Australia
Westmead
Westmead (Greater Sydney), New South Wales (NSW), Australia
South Coast Renal
Southport, Queensland (QLD), Australia
Loading map...
Who is running the clinical trial?
ClinicalOne
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
What is the study measuring?
Primary Outcome
Secondary Outcome
References
Clinical Trials Gov: ADPKD clinical study (Kidney study)Other trials to consider
Loading suggested trials...
